Braver elected to American Academy of Arts & Sciences
WashU neuroscientist Todd Braver has been elected to the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies.
Rudra named member of NIH study section
Jai Rudra, an associate professor of biomedical engineering at WashU McKelvey Engineering, will serve on the National Institues of Health (NIH)’s Vaccines Against Infectious Diseases study section.
Huang installed as inaugural Davie professor
Eric Huang, MD, PhD, a leader in the study of human brain development, has been named the inaugural Joseph M. Davie Distinguished Professor in Pathology & Immunology at WashU Medicine.
Unique markers of neurodegenerative disease mapped in blood, spinal fluid
A study led by WashU Medicine researchers reveals molecular insights into Alzheimer’s disease, Parkinson’s disease and other dementias that could lead to earlier, more precise diagnoses.
Hengen wins NIH grant to study sleep’s role in Alzheimer’s treatment
Researchers at WashU have won $2.7 million from the National Institutes of Health (NIH) for a five-year investigation into the power of sleep to prevent, delay and diminish Alzheimer’s and other neurodegenerative diseases.
Supporting runners every step of the way
WashU Medicine serves as the official medical provider — and more — at the Greater St. Louis Marathon.
$12 million NIH grant supports study of Alzheimer’s risk factors
Researchers at WashU Medicine will investigate genetic and molecular factors behind the disease’s disproportionate prevalence in Caribbean populations, with the aim of identifying new drug targets.
Teaching Public Health
Volume Two
In an era shaped by the seismic effects of the COVID-19 pandemic and politically derived challenges, the second volume of “Teaching Public Health” offers a timely and essential contribution to the evolving field of public health education.
Grants bolster research on myelodysplastic syndromes
Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.
mRNA vaccines follow unconventional immune path to destroy tumors
WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.
Older Stories